Literature DB >> 23278129

Dendritic cells from human mesenteric lymph nodes in inflammatory and non-inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells.

Arwed Hostmann1, Kerstin Kapp, Marianne Beutner, Jörg-Peter Ritz, Christoph Loddenkemper, Ralf Ignatius, Rainer Duchmann, Severin Daum, Jörn Gröne, Hubert Hotz, Heinz-Johannes Buhr, Martin Zeitz, Reiner Ullrich.   

Abstract

Plasmacytoid dendritic cells (pDC) in mesenteric lymph nodes (MLN) may be important regulators of both inflammatory and non-inflammatory mucosal immune responses but human studies are rare. Here we compare pDC from human MLN and peripheral blood (PB) by phenotype and function. MLN from patients with or without inflammatory bowel disease (IBD) undergoing colon surgery and PB from patients with IBD and from controls were used to isolate mononuclear cells. The pDC were analysed by flow cytometry for the expression of CD40, CD80, CD83, CD86, CCR6, CCR7, CX3CR1, CD103 and HLA-DR. Purified pDC from MLN and PB were stimulated with staphylococcus enterotoxin B (SEB), CpG-A, interleukin-3 (IL-3), SEB + IL-3, CpG-A + IL-3 or left unstimulated, and cultured alone or with purified allogeneic CD4(+) CD45RA(+) HLA-DR- T cells. Subsequently, concentrations of IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, interferon-α (IFN-α), IFN-γ and tumour necrosis factor-α (TNF-α) in culture supernatants were determined by multiplex bead array. The PB pDC from IBD patients exhibited an activated and matured phenotype whereas MLN pDC and control PB pDC were less activated. CpG-A and CpG-A + IL-3-stimulated MLN pDC secreted less IL-6 and TNF-α compared with PB pDC from controls. Compared with co-cultures of naive CD4 T cells with PB pDC, co-cultures with MLN pDC contained more IL-2, IL-10 and IFN-γ when stimulated with SEB and SEB + IL-3, and less IFN-α when stimulated with CpG-A. MLN pDC differ phenotypically from PB pDC and their pattern of cytokine secretion and may contribute to specific outcomes of mucosal immune reactions.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23278129      PMCID: PMC3634542          DOI: 10.1111/imm.12060

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  54 in total

1.  Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.

Authors:  Atsushi Sakuraba; Toshiro Sato; Nobuhiko Kamada; Mina Kitazume; Akira Sugita; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

Review 2.  The bacterial superantigen and superantigen-like proteins.

Authors:  John D Fraser; Thomas Proft
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 3.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

4.  Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement.

Authors:  Dorit Fabricius; Marina Neubauer; Birgit Mandel; Catharina Schütz; Andreas Viardot; Angelika Vollmer; Bernd Jahrsdörfer; Klaus-Michael Debatin
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

5.  Plasmacytoid dendritic cells mediate oral tolerance.

Authors:  Anne Goubier; Bertrand Dubois; Hanane Gheit; Grégoire Joubert; Florence Villard-Truc; Carine Asselin-Paturel; Giorgio Trinchieri; Dominique Kaiserlian
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

6.  Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.

Authors:  Vincent Lombardi; Laurence Van Overtvelt; Stéphane Horiot; Philippe Moingeon
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Origin of the lamina propria dendritic cell network.

Authors:  Milena Bogunovic; Florent Ginhoux; Julie Helft; Limin Shang; Daigo Hashimoto; Melanie Greter; Kang Liu; Claudia Jakubzick; Molly A Ingersoll; Marylene Leboeuf; E Richard Stanley; Michel Nussenzweig; Sergio A Lira; Gwendalyn J Randolph; Miriam Merad
Journal:  Immunity       Date:  2009-09-10       Impact factor: 31.745

8.  Intestinal lamina propria dendritic cell subsets have different origin and functions.

Authors:  Chen Varol; Alexandra Vallon-Eberhard; Eran Elinav; Tegest Aychek; Yami Shapira; Hervé Luche; Hans Jörg Fehling; Wolf-Dietrich Hardt; Guy Shakhar; Steffen Jung
Journal:  Immunity       Date:  2009-09-03       Impact factor: 31.745

9.  Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.

Authors:  Bertrand Dubois; Grégoire Joubert; Mercedes Gomez de Agüero; Marie Gouanvic; Anne Goubier; Dominique Kaiserlian
Journal:  Gastroenterology       Date:  2009-04-01       Impact factor: 22.682

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  6 in total

1.  Transcriptomic Analysis and High-dimensional Phenotypic Mapping of Mononuclear Phagocytes in Mesenteric Lymph Nodes Reveal Differences Between Ulcerative Colitis and Crohn's Disease.

Authors:  Laurence Chapuy; Marwa Bsat; Manuel Rubio; François Harvey; Vinicius Motta; Frank Schwenter; Ramses Wassef; Carole Richard; Colette Deslandres; Bich N Nguyen; Geneviève Soucy; Nir Hacohen; Jorge Fritz; Alexandra-Chloé Villani; Heena Mehta; Marika Sarfati
Journal:  J Crohns Colitis       Date:  2020-03-13       Impact factor: 9.071

2.  Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells.

Authors:  Elena Lo Presti; Nadia Caccamo; Valentina Orlando; Francesco Dieli; Serena Meraviglia
Journal:  Oncotarget       Date:  2016-09-20

3.  Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease.

Authors:  Natasa Smrekar; David Drobne; Lojze M Smid; Ivan Ferkolj; Borut Stabuc; Alojz Ihan; Andreja Natasa Kopitar
Journal:  Radiol Oncol       Date:  2018-11-26       Impact factor: 2.991

Review 4.  The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease.

Authors:  Dimitrios Nikolakis; Floris A E de Voogd; Maarten J Pruijt; Joep Grootjans; Marleen G van de Sande; Geert R D'Haens
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 5.  Stem Cell-Based Therapies for Inflammatory Bowel Disease.

Authors:  Hua-Min Zhang; Shuo Yuan; Huan Meng; Xiao-Ting Hou; Jiao Li; Jia-Chen Xue; You Li; Qi Wang; Ji-Xing Nan; Xue-Jun Jin; Qing-Gao Zhang
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

6.  Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions.

Authors:  Kunal Kapoor; Nour Eissa; Diane Tshikudi; Charles N Bernstein; Jean-Eric Ghia
Journal:  World J Gastroenterol       Date:  2021-12-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.